Myeloid malignancies and the marrow microenvironment: some recent studies in patients with MDS

AM Marcondes, A Ramakrishnan… - Current cancer therapy …, 2009 - ingentaconnect.com
There is growing evidence for a role of the hemopoietic microenvironment in the
pathophysiology of myelodysplastic syndromes (MDS). Effects of various cytokines on the …

Future patient incidence in hemato-oncology: a study using data from cancer registries in Japan

H Narimatsu, M Sakaguchi, S Nakamura… - … and Healthcare Policy, 2020 - Taylor & Francis
Purpose The distribution of patients with hematological malignancies is expected to change
markedly in the future due to aging of the Japanese population. We assessed the expected …

Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach

J Sinkovics - Acta Microbiologica et Immunologica Hungarica, 2010 - akjournals.com
In leukemic mice, the native host's explicit and well-defined immune reactions to the
leukemia virus (a strong exogenous antigen) and to leukemia cells (pretending in their …

Bone marrow CD34+ cells expanded on human brain endothelial cells reconstitute lethally irradiated baboons in a variable manner

H Araki, JP Chute, B Petro, L Halliday… - Leukemia & …, 2010 - Taylor & Francis
Increased cell dose has a positive impact on the therapeutic outcome of bone marrow (BM)
hematopoietic stem cell (HSC) transplant. However, methods to successfully expand BM …

[PDF][PDF] Future patient distribution and incidence in hemato-oncology: a study using data

M Sakaguchi, K Katayama, H Narimatsu - scholar.archive.org
Original Article Title: Future patient distribution and incidence in hemato-oncology: a study using
data from the cancer registr Page 1 1 1 Original Article Title: Future patient distribution and …

Future patient distribution and incidence in hemato-oncology: a study using data from the cancer registry in Kanagawa, Japan

H Narimatsu, S Nakamura, M Sakaguchi, K Katayama - 2020 - researchsquare.com
BACKGROUND AND PURPOSE The distribution of patients with hematological
malignancies will probably markedly change because society is aging. We assessed the …

[引用][C] Liječenje vlastitim matičnim hematopoetskim stanicama

G Sabo